TSX:CVE - Post Discussion
Post by
retiredcf on Apr 27, 2023 8:30am
TD
Cenovus Energy Inc.
(CVE-T, CVE-N) C$23.18 | US$16.35
Q1/23 Conference Call Highlights and Updated Estimates
Event
Updated estimates following Q1/23 call (highlights below). Initial thoughts here.
Impact: NEUTRAL
-
Despite a noisy Q1/23, CVE remains confident in its ability to execute within its U.S. refining portfolio: Using the solid performance of the Lloyd Upgrader/ Asphalt Refinery and Lima Refinery as a proxy (i.e. since being acquired from HSE in 2021), CVE believes in its ability to replicate similarly strong utilization and margins at Superior/Toledo once they are fully ramped-up in H2/23.
Superior/Toledo expected to strengthen heavy oil value chain: Recall, Superior/Toledo have combined heavy processing capacity of 124 mbbl/d, increasing total U.S. heavy processing capacity to ~302 mbbl/d (net). In addition, CVE will consume ~400 mbbl/d of heavy blend (~50% of heavy blend production of ~800 mbbl/d) once all refineries are up-and-running.
-
Management also expecting a step-change in upstream operating performance heading into H2/23: As part of its near-term growth plans (note), CVE plans to bring on three pads at each of Foster Creek and Christina Lake in H2/23. We highlight that these pad additions coincide with the expected start-up of TMX in Q1/24, and note that we estimate TMX can support 2-4 years of heavy production growth based on historical trends and current production (note).
With Lloyd thermals production now sitting comfortably at >100 mbbl/d (following implementation of its lower-cost operating model), CVE has now set its sights on Sunrise. Here, it plans to bring production to nameplate capacity (60 mbbl/d) over the next 18 months, with line of sight to additional future debottlenecking opportunities.
-
As expected, management confirmed its near-term preference for opportunistic buybacks over variable dividends: Considering CVE's share price is down ~30% from Q2/22 highs (-14% YTD vs. peers +2%), this does not surprise us at all.
TD Investment Conclusion
Although this was an unusually tough quarter for CVE, the fundamental outlook remains constructive, in our view, especially since value-enhancing opportunities continue to be uncovered within the HSE portfolio. Notwithstanding the recent delay, transitioning to a 100% return of excess FFF in Q4/23 (from 50%) will also serve to put CVE on a competitive footing, in our view. Our target price falls to $29/share on revised financial estimates.
Be the first to comment on this post